Seller record · Telehealth service

BeyondMD

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The program pages, the process page and the about page refer only to licensed US 503A compounding pharmacies and certified pharmacy partners. 2 more criteria also fail; see the table below.

At a glance

BeyondMDTelehealth service

5/8criteria passed
Price
Compounded semaglutide from $125, compounded tirzepatide from $199
Sells
compounded semaglutide injection, semaglutide with B12, and 16 more
FDA letters
None on file
Visit BeyondMDSee all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A Michigan-based telehealth platform selling compounded semaglutide and tirzepatide as injections and tablets, a microdose GLP-1 program, brand Wegovy and Zepbound consultations, and a wide peptide range including tesamorelin, sermorelin, NAD+, PT-141 and GHK-Cu. Care starts with an online intake and a telehealth visit, and no pharmacy is named.

Operating entity Prescribery Corp.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSBeyondMD's our process page; BeyondMD's terms of service page; BeyondMD's website
S2Prescription gatingPASSBeyondMD's our process page
S3Pharmacy identificationFAILBeyondMD's our process page; BeyondMD's about page; BeyondMD's compounded semaglutide injections page
S4Compounding disclosureFAILBeyondMD's compounded semaglutide injections page; BeyondMD's compounded tirzepatide injections page; BeyondMD's weight management and metabolism page
S5Analytical documentationFAILBeyondMD's weight management and metabolism page; BeyondMD's our process page; BeyondMD's terms of service page
S6Business addressPASSBeyondMD's terms of service page; BeyondMD's privacy policy; BeyondMD's website
S7Price disclosurePASSBeyondMD's weight management and metabolism page; BeyondMD's all programs page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA US-licensed clinician meets each patient in a private telehealth consultation after the intake and approves any treatment, and the terms say no prescription product is available without a consultation in which a provider finds it appropriate. The home page names its clinicians.Source: BeyondMD's our process page; BeyondMD's terms of service page; BeyondMD's website.
S2PASSThe process page says a buyer submits an intake form and then has a telehealth consultation, and is charged only if approved for treatment.Source: BeyondMD's our process page.
S3FAILNo filling pharmacy is named. The program pages, the process page and the about page refer only to licensed US 503A compounding pharmacies and certified pharmacy partners.Source: BeyondMD's our process page; BeyondMD's about page; BeyondMD's compounded semaglutide injections page.
S4FAILThe compounded semaglutide and tirzepatide pages carry no statement that the compounded drugs are not FDA-approved. The footer and the answers say only that many peptide therapies are not FDA-approved for the uses discussed, and the plain statement appears only in a separate consent document.Source: BeyondMD's compounded semaglutide injections page; BeyondMD's compounded tirzepatide injections page; BeyondMD's weight management and metabolism page.
S5FAILNo certificate of analysis or lot document is published on the program pages, the process page, the terms or the refund policy.Source: BeyondMD's weight management and metabolism page; BeyondMD's our process page; BeyondMD's terms of service page.
S6PASS811 E. Kent Rd, Greenville, MI 48838, printed in the footer of every page, beside Prescribery Corp. in the contact block of the terms and in the contact block of the privacy policy.Source: BeyondMD's terms of service page; BeyondMD's privacy policy; BeyondMD's website.
S7PASSCompounded semaglutide injections from $125, semaglutide with B12 and the microdose GLP-1 program from $125, compounded tirzepatide injections from $199, oral semaglutide from $149 and oral tirzepatide from $249. Wegovy and Zepbound consultations from $129. Sermorelin injections from $179, NAD+ injections from $199 and PT-141 from $219. The program cards do not say what period each price covers.Source: BeyondMD's weight management and metabolism page; BeyondMD's all programs page.
S8PASSNo FDA warning letter names BeyondMD or Prescribery Corp., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection, semaglutide with B12, microdose GLP-1 injections, compounded tirzepatide injection, oral semaglutide, oral tirzepatide, Wegovy consultation, Zepbound consultation, tesamorelin, sermorelin injection and oral sermorelin, NAD+ injection, nasal spray, oral and face cream, PT-141 injection and nasal spray, GHK-Cu oral and topical, glutathione, VIP nasal spray, oxytocin nasal spray, testosterone replacement therapy, sildenafil, tadalafil and vardenafil.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells glutathioneWho sells PT-141Who sells GHK-CuWho sells tesamorelin

Visit BeyondMD

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.